Tectonic Therapeutic

Hemab Therapeutics

This biotechnology company develops prophylactic antibody-based therapies for patients with rare bleeding and thrombotic disorders such as Glanzmann thrombasthenia and von Willebrand disease.

Septerna, Inc

This biotechnology company develops small-molecule medicines targeting G protein-coupled receptors to treat patients with endocrine, inflammatory and metabolic diseases.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.

Epitome Therapeutics

This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.

Diagonal Therapeutics

This biotechnology company develops agonist antibody treatments for patients with rare genetic diseases like hereditary haemorrhagic telangiectasia and pulmonary arterial hypertension.

HemaB

Hemab Therapeutics develops prophylactic antibody therapies for patients with rare bleeding and thrombotic disorders including Glanzmann thrombasthenia and Factor VII deficiency.

RougeTx

This biotechnology company develops small-molecule therapies that restore vascular stability to treat patients with hereditary haemorrhagic telangiectasia and other bleeding disorders.

Protego Biopharma

This biotechnology company develops small molecule therapies for patients with systemic amyloid diseases and other protein misfolding disorders.